Literature DB >> 18706889

dnRas stimulates autocrine-paracrine growth of regenerating muscle via calcineurin-NFAT-IL-4 pathway.

Erno Zádor1.   

Abstract

Ras and calcineurin are members of two independent pathways in muscle growth but their interaction is not known. This work shows that the transfection of about 1% of the muscle fibers with dominant negative Ras (dnRas) shows a wilder effect; it stimulates the fiber growth in the entire regenerating soleus muscle, including the nontransfected fibers. Co-transfection with the calcineurin inhibitor cain/cabin prevented the growth stimulation. Injection of antibody for interleukin-4 (IL-4) also abolished the growth ameliorating effect. These results suggest that the inactivation of Ras in 1% of the fibers upregulates the calcineurin-NFAT-IL-4 pathway and the secreted IL-4 triggers fiber growth stimulation in the whole regenerating soleus muscle of the rat. The results highlight the importance of the autocrine-paracrine regulation in muscle regeneration and hint to a novel method of gene theraphy of degenerative-regenerative muscle dystrophies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706889     DOI: 10.1016/j.bbrc.2008.08.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Follistatin treatment suppresses SERCA1b levels independently of other players of calcium homeostasis in C2C12 myotubes.

Authors:  János Fodor; Adrienn Gomba-Tóth; Tamás Oláh; János Almássy; Ernő Zádor; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2017-06-21       Impact factor: 2.698

2.  Silencing SERCA1b in a few fibers stimulates growth in the entire regenerating soleus muscle.

Authors:  Erno Zádor; Grzegorz Owsianik; Frank Wuytack
Journal:  Histochem Cell Biol       Date:  2010-12-01       Impact factor: 4.304

3.  Transfection efficiency along the regenerating soleus muscle of the rat.

Authors:  Magdolna Kósa; Ernő Zádor
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.